Roivant Sciences (ROIV) Other Non-Current Liabilities (2021 - 2026)

Roivant Sciences (ROIV) has reported Other Non-Current Liabilities for 6 consecutive years, with $6.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities rose 2642.54% year-over-year to $6.3 million; the trailing twelve-month figure through Jun 2026 stood at $6.3 million (up 2642.54% YoY), and the FY2026 full-year result was $38.7 million, up 175672.73% from the prior year.
• Other Non-Current Liabilities fell to $6.3 million in Q2 2026 per ROIV's latest filing, from $38.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $38.7 million in Q1 2026 and bottomed at $22000.0 in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $8.6 million across 5 years, with a median of $4.8 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities sank 99.12% in 2025, then soared 175672.73% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $21.5 million in 2022, then plunged by 79.38% to $4.4 million in 2023, then plunged by 93.07% to $307000.0 in 2024, then jumped by 120.52% to $677000.0 in 2025, then jumped by 823.63% to $6.3 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $6.3 million, $38.7 million, and $677000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.